AAM Blasts Bipartisan Bill Altering 180-Day Generic Exclusivity

Drug Industry Daily
A A
The Association for Accessible Medicines is sounding the alarm on a House bill that would alter 180-day exclusivity for generics to allow for faster market entry of competitors.

To View This Article:

Login

Subscribe To Drug Industry Daily